Tag Archives: AstraZeneca

Eli Lilly yesterday announced a partnership with U. K. drug maker AstraZeneca to develop and commercialize a potential new drug for Alzheimer’s.  AstraZeneca will produce the drug, ASD3293, and Lilly will lead the clinical trials.  The drug is one of a class of drugs called BASE inhibitors.   BASE inhibitors inhibit an enzyme, beta-secretase, which is involved in forming the plaques …

Podcast: Play in new window | Download (Duration: 28:55 — 26.5MB)Subscribe: RSS | MoreEli Lilly yesterday announced a partnership with U. K. drug maker AstraZeneca to develop and commercialize a potential new drug for Alzheimer’s; Indiana Attorney General Greg Zoeller joined collegues in thirty-seven states urging the FCC to allow more extensive use of call blocking technologies; The Alzheimer’s Association …